Oral Presentation
Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
08:30
Late Breaking Abstract - Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study_Update
J. Pépin(Grenoble, France)
COI
1
08:45
Distinguishing Patients with Central from Obstructive Sleep Apnea Using Overnight Breath Sound Recordings
H. Alshaer(Toronto (ON), Canada)
COI
2
09:00
Loop Gain in Heart Failure Patients with Periodic Breathing
S. Herkenrath(Köln, Germany)
COI
3
09:15
Association of obstructive sleep apnoea but not central sleep apnoea and spheric remodeling of left ventricle in patients with ST-segment elevation anterior myocardial infarction
C. Fisser(Regensburg, Germany)
COI
4
09:30
Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA).
O. Krakhmalova(Kharkiv, Ukraine)
COI
5
09:45
Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA)
C. Gunduz(İstanbul, Turkey)
COI
6
10:00
OSA and cancer in Europe: the European Sleep Apnea Database (ESADA) experience
A. Pataka(Thessaloniki, Greece)
COI
7
10:15
CPAP appears to protect kidney function of patients with OSA.
J. Wingfield Digby(Manchester (Greater Manchester), United Kingdom)
COI
8
. . .
